Back to search results

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

Abroad (travel likely)RecruitingPHASE3

Conditions

Acute Respiratory Distress Syndrome · ARDS

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Direct Biologics Investigational Site, Phoenix, Arizona, United States

  • Direct Biologics Investigational Site, Little Rock, Arkansas, United States

  • Direct Biologics Investigational Site, Davis, California, United States

  • Direct Biologics Investigational Site, Irvine, California, United States

  • Direct Biologics Investigational Site, Sacramento, California, United States

  • Direct Biologics Investigational Site, Washington D.C., District of Columbia, United States

  • Direct Biologics Investigational Site, Jacksonville, Florida, United States

  • Direct Biologics Investigational Site, Boise, Idaho, United States

  • Direct Biologics Investigational Site, Iowa City, Iowa, United States

  • Direct Biologics Investigational Site, Silver Spring, Maryland, United States

  • Direct Biologics Investigational Site, Boston, Massachusetts, United States

  • Direct Biologics Investigational Site, Burlington, Massachusetts, United States

  • Direct Biologics Investigational Site, Springfield, Massachusetts, United States

  • Direct Biologics Investigational Site, Detroit, Michigan, United States

  • Direct Biologics Investigational Site, Rochester, Minnesota, United States

  • Direct Biologics Investigational Site, Jackson, Mississippi, United States

  • Direct Biologics Investigational Site, Flushing, New York, United States

  • Direct Biologics Investigational Site, Queens, New York, United States

  • Direct Biologics Investigational Site, The Bronx, New York, United States

  • Direct Biologics Investigational Site, Durham, North Carolina, United States

  • Direct Biologics Investigational Site, Winston-Salem, North Carolina, United States

  • Direct Biologics Investigational Site, Cincinnati, Ohio, United States

  • Direct Biologics Investigational Site, Cleveland, Ohio, United States

  • Direct Biologics Investigational Site, Portland, Oregon, United States

  • Direct Biologics Investigational Site, Charleston, South Carolina, United States

  • Direct Biologics Investigational Site, Knoxville, Tennessee, United States

  • Direct Biologics Investigational Site, Nashville, Tennessee, United States

  • Direct Biologics Investigational Site, Dallas, Texas, United States

  • Direct Biologics Investigational Site, Fort Worth, Texas, United States

  • Direct Biologics Investigational Site, Houston, Texas, United States

  • Direct Biologics Investigational Site, Murray, Utah, United States

  • Direct Biologics Investigational Site, Salt Lake City, Utah, United States

Study leads

  • Bill Arana

    Study Director

    Direct Biologics, LLC

View source on ClinicalTrials.gov(opens in a new tab)